News

15
Feb

Genoskin at SOT 63rd Annual Meeting and ToxExpo

Genoskin at SOT 63rd Annual Meeting and ToxExpoPioneering Human Skin Models for Advanced Toxicology ResearchAs the world of toxicology convened for the Society of Toxicology 63rd Annual Meeting and ToxExpo, Genoskin was excited to announce its participation in this event, which took place from March 10-14 at the Salt Palace Convention Center in Salt Lake City. This year, Genoskin showcased
Read more
9
Feb

Understanding Local Tolerance

Understanding Local Tolerancein Drug DevelopmentIn the ever-evolving field of drug development, ensuring the safety and efficacy of new therapeutic agents is paramount. A crucial aspect of this safety evaluation is the assessment of cytotoxicity – the potential of substances to harm or destroy cells. Particularly in the realm of skin cytotoxicity, the concept of Local Tolerance, especially in the context
Read more
10
Jan

Immunogenicity series: Defining immunogenicity

Immunogenicity SeriesPart 1 - Defining immunogenicity Immunogenicity plays a pivotal role in drug and vaccine development and is essential for optimizing therapeutic efficacy and safetyby understanding the immune system's response to the compounds being tested. This is particularly crucial in the era of biologics and personalized medicine, where the fine balance between therapeutic benefit and immune reactivity is critical. Whether
Read more
23
Nov

Discover how VaxSkin® can transform your vaccine development

Research HighlightOur latest publication is now available! Discover how VaxSkin® can transform your vaccine development.The landscape of vaccine research is undergoing an important transformation, thanks to the breakthroughs in mRNA vaccine technology.This innovation has catalyzed the development of vaccines that are not only highly effective but also rapidly deployable at a large scale. With the increasing number of research institutions,
Read more
1
Nov

Technicien de laboratoire, culture tissulaire

Technicien de laboratoire, culture tissulaire L'équipe s'agrandit. Rejoignez nos laboratoire à Toulouse. Ref: GEN23.10.02 Société:GENOSKIN SAS Date de début : Dès que possible Contrat:  CDI Lieu: Centre Pierre Potier - Oncopole, 1 place Pierre Potier, 31100 TOULOUSE Niveau d'études : Bac+3 en biochimie, biologie cellulaire, biotechnologies Niveau d'expérience : 5 à 10 ans d’expérience en culture cellulaire et/ou tissulaire Secteur
Read more
31
Oct

The Role of Animal-Free Non-Clinical Platforms in Drug Development – Part 2

Redefining Local Toxicity AssessmentPart 2 - The Role of Animal-Free Non-Clinical Platforms in Drug Development. In the realm of non-clinical animal-free platforms, a transformative shift is unfolding in response to the challenges posed by drug-induced adverse reactionsa predominant factor leading to the discontinuation of drug development projects and the withdrawal of drugs from the market1. The imperative for accurate, ethical,
Read more